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ABSTRACT
Aims It is well established that tobacco use is associated with mental disorders. However, the association between
tobacco use and mental disorders has not yet been examined sufficiently in prospective, population-based studies. The
current study is aimed at examining whether smoking is associated with first-ever incidence of mental disorders.
Design, setting and participants We conducted a prospective, population-based epidemiological study (the
Netherlands Mental Health Survey and Incidence Study: NEMESIS) in which a representative sample of adults
aged 18–64 years (n = 7076) were interviewed to establish the presence of a broad range of mental disorders.
We re-interviewed them at 1 year (n = 5618; response 79.4%) and 3 years (n = 4796; 67.8%) after baseline.
Measurements The presence of mental disorders was assessed according to DSM-III-R criteria with the Composite
International Diagnostic Interview (CIDI), which was administered by trained lay interviewers. Tobacco use was
assessed by asking respondents whether they had smoked in the past year, and how many cigarettes they
smoked. Findings Subjects who smoked but never had a mental disorder in their life, had an increased risk of
developing a mental disorder (P < 0.01), and this remained significant after correcting for major risk indicators of
mental disorders. Conclusions Smoking is associated not only with the prevalence, but also with first-ever incidence
of mental disorders. More research is needed to study the causal pathways.
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INTRODUCTION
It is well established that tobacco use is elevated in sub-
jects with mental disorders [1], including schizophrenia
[2], bipolar disorder [3], panic disorder [4], major depres-
sion [5–7] and alcohol-related disorders [8,9]. The exact
causal pathways are not clear. It has been assumed that
tobacco is used by people with mental disorders as self-
medication [10–12]; in other words, that tobacco use is
‘caused’ by the mental disorder, and not the other way
around. Several recent studies, however, suggest that
smokingmay be associated with an increased risk of trig-
gering the onset of mental disorders, including panic [4],
depression [6,7] and schizophrenia [13]. It is also entirely
possible that both smoking and mental disorders are
caused by a third, unrelated, factor [14,15]. The few pro-
spective studies in this research area have examined the
association between smoking and depression. Some of
these studies have found that smoking at baseline predicts
the onset of depression [7,16], while others did not
confirm this finding [17,18].
Epidemiological research in this area suffers from
major limitations [1]. Many of the studies focus on only
one mental disorder; do not use diagnostic interviews to
assess the presence of mental disorders, but use self-
rating questionnaires instead; are conducted in clinical
and other non-representative samples; and are cross-
sectional instead of prospective.
However, representative, prospective population-
based studies examining a broad range of mental disor-
ders and using rigorous diagnostic criteria can help in
answering several important questions on the relation-
ship between smoking and mental disorders. One impor-
tant question is whether there is a temporal association
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between smoking and first-ever incidence of mental dis-
orders. Another question is whether there is a dose–
response relationship between the number of cigarettes
smoked and the onset of first-ever incidence of mental
disorders. A dose–response relationship can be seen as an
indication for a causal relationship between a risk indica-
tor and an outcome [19]. A third important question is
whether the presence of mental disorders is associated
with the (re)starting of smoking. In this study, these ques-
tions were examined.
METHOD
Subjects and procedure
The Netherlands Mental Health Survey and Incidence
Study (NEMESIS) was based on a multi-stage, stratified,
random sampling procedure [20,21]. In brief, a sample
of 90 municipalities was drawn, using urbanization
as stratification criterion; the sample resulted in an
adequate distribution of the respondents over the 12
Dutch provinces. A sample of private households was
then drawn from the postal registers. The selected house-
holds were first sent a letter of introduction, followed by a
telephone contact. In each household, the member with
the most recent birthday was selected, on condition that
(s)he was between 18 and 64 years and sufficiently fluent
in Dutch to be interviewed.To establish contact, the inter-
viewers made a minimum of 10 phone calls or visits to a
given address at different times of the day and week.
In the initial data collection phase, 7076 respondents
were interviewed (year of interview: 1996; response rate
69.7%). All participants in the first interview (t0) were
approached for the follow-up waves at 1 year (t1) and
3 years (t2) after t0. Of the 7076 people who had taken
part at t0, 5618 could be re-interviewed at t1 (response:
79.4%) and 4796 at t2 (response of t0 subjects: 67.8%).
After adjustment for demographic variables, a 12-month
disorder at t0 only slightly increased the probability of loss
to follow-up between t0 and t1 as well as between t0 and t2
(OR = 1.20, CI = 1.04–1.38; OR = 1.29, CI = 1.15–1.46)
[22,23]. Smoking also somewhat increased the probabil-
ity of loss to follow-up between t1 and t2 (OR = 1.24,
CI = 1.06–1.45).
To correct for the combined effect of initial non-
response and dropout, post-stratification weights were
calculated.
Measures
Mental disorders
Mental disorders were assessed according to DSM-III-R
criteria. The instrument used was the Composite Interna-
tional Diagnostic Interview (CIDI, version 1.1) [24],
Dutch version [25]. The CIDI can be used by trained lay
interviewers. It is known to have a high inter-rater and
test–retest reliability [26]. In the current study,we use the
diagnoses of the most common mood disorders, anxiety
disorders and substance-use disorders. The specific disor-
ders are described in Table 1. Schizophrenia and eating
disorders were not included in this study because the
numbers of subjects were very small (n < 6 for both dis-
orders). The CIDI was administered to all respondents at
all three measurements.
Tobacco use
Tobacco use was assessed at t1 and at t2 by asking respon-
dents whether they had smoked in the past year at t1 and
past 2 years at t2 (yes/no). We also asked howmany ciga-
rettes they smoked. For further analyses, we made four
categories of the number of cigarettes smoked per day
(zero; one to nine; 10–19; > 20). We did not assess other
types of tobacco use (such as cigars, pipe or chewing
tobacco), as these are hardly used in the Netherlands.
Risk indicators of mental disorders
In the prospective part of our study we controlled for
other risk indicators of mental disorders, apart from
smoking. We selected a number of risk indicators that
were found to be predictive of mood and anxiety disorders
in several other studies [27], including studies on the
NEMESIS data [28,29]:
• Childhood trauma, i.e. emotional neglect, psychologi-
cal abuse, physical abuse and sexual abuse before the
age of 16. During the interviews, the abuse types were
explained to the respondents and illustrated with
examples. In our analyses, we used dichotomous vari-
ables which indicated the presence or absence of these
four types of trauma at t0.
• Parental history of psychopathology concerned depres-
sive problems, anxiety or phobic problems and problem
drinking in one or both biological parents, assessed at
t0. The presence or absence of parental history was
assessed by single questions [30].
• Somatic illnesses: the presence of somatic disorders
(migraine, lower back pain, complaints pointing
towards cardiovascular, respiratory and non-specific
abdominal problems) in the 12 months preceding t1.
We used one variable indicating the presence or
absence of any somatic disorder in the past 12months.
• Locus of control was measured with the Mastery Scale
[31]. We defined low mastery, indicating an external
locus of control (= 1, else =0) as a score below themean
of the sample at t1 (M = 19.3; Cronbach’s a = 0.81).
• Neuroticism was assessed with the Groningse Neuroti-
cism Questionnaire [32]. We used a cut-off at the mean
to obtain an indicator for above-average levels of neu-
roticism (M = 38.5; a = 0.80).
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Demographic variables
Demographic variables included: gender, age, education
(lower versus higher), and having a paid job or not.
Analyses
Because smoking was assessed at t1 and t2, we used the
data of these two waves in the current study.
At t1, we examined whether there was a cross-
sectional association between smoking and mental
disorders. We conducted a series of Poisson regression
analyses with smoking in the past year as the dependent
variable (yes/no), and each of the mental disorders as a
predictor, while adjusting for demographics. We
conducted separate analyses for the 12-month and the
life-time prevalences of mental disorders. In these cross-
sectional analyses, Poisson regression models produce
relative risks (RR), indicating whether having a mental
disorder is associated with a higher probability of
smoking than when there is no disorder.
We then examined longitudinally whether subjects
who smoked at t1 had an increased risk of developing a
mental disorder for the first time in their lives at t2. We
selected the subjects who had never had any mental dis-
order in their life. In a new series of Poisson regression
analyses, we used each of the variables indicating first-
ever incidence of amental disorder as the dependent vari-
able. Smoking in the year before t1 (yes/no) was used as a
predictor. In the first series of Poisson regression analy-
ses, we adjusted the outcomes for demographics. In the
second series, we adjusted for demographics and for all
risk indicators as described in the ‘Measures’ section. In
the context of longitudinal data analysis, the Poisson
model produces incidence rate ratios (IRRs). These are
the ratios of the incidence rate in the exposed group over
the incidence rate in the unexposed group.
We next examined whether there is a dose–response
relationship between the number of cigarettes smoked
and the degree to which the risk of developing a first-ever
mental disorder is elevated. In this series of Poisson
regression analyses, we used first-ever incidence of
mental disorders at t2 as the dependent variable and the
number of cigarettes smoked at t1 as predictor, while
adjusting for demographics. We conducted the same
analyses again, with four categories of smoking (zero;
one to nine; 10–19;  20 cigarettes).
To examine whether subjects with a mental disorder
have an increased risk of (re)starting to smoke, we used
another series of Poisson regression analyses.We selected
subjects who had not smoked in the year prior to t1, and
Table 1 Smoking in the past 12 months among subjects with mental disorders in the past 12 months and life-time.
12 months Life-time
Prevalence % smoking RR 95% CI P Prevalence % smoking RR 95% CI P
Any anxiety disorder 7.1 50.9 1.33 1.18–1.50 *** 21.5 48.9 1.26 1.15–1.37 ***
GADa 0.5 52.8 1.46 0.99–2.15 NS 2.5 53.0 1.33 1.11–1.59 **
Panic disorderb 1.3 58.5 1.49 1.19–1.87 ** 4.7 51.1 1.26 1.08–1.47 **
Agoraphobia 1.1 65.0 1.68 1.39–2.03 *** 4.0 54.2 1.43 1.25–1.64 ***
Social phobia 2.2 56.0 1.44 1.20–1.73 *** 8.2 51.2 1.31 1.17–1.47 ***
Simple phobia 4.3 48.3 1.21 1.03–1.42 * 12.3 49.1 1.19 1.07–1.33 **
OCDc 0.4 45.2 1.00 0.53–1.87 NS 0.5 43.7 1.12 0.82–1.53 NS
Any mood disorder 5.8 53.1 1.39 1.22–1.57 *** 21.1 51.2 1.44 1.33–1.56 ***
Major depression 4.6 52.5 1.35 1.17–1.56 *** 8.8 51.0 1.40 1.28–1.52 ***
Dysthymia 1.1 61.8 1.73 1.37–2.19 *** 7.2 50.4 1.38 1.23–1.54 **
Bipolar disorder 0.9 60.0 1.62 1.26–2.09 *** 2.3 60.0 1.49 1.26–1.77 ***
Any substance use disorder 6.0 62.4 1.43 1.18–1.74 *** 20.9 58.7 1.49 1.36–1.64 ***
Alcohol abuse 5.5 56.5 1.30 0.98–1.72 NS 14.7 55.8 1.34 1.19–1.49 ***
Alcohol dependence 1.5 74.2 1.62 1.32–1.98 *** 5.9 68.9 1.57 1.39–1.77 ***
Drug abuse/ 0.5 80.6 1.71 1.38–2.10 *** 2.0 72.4 1.50 1.23–1.83 ***
Drug dependence 0.6 78.5 1.59 1.22–2.07 ** 2.2 71.9 1.65 1.42–1.91 ***
Any diagnosis 15.8 53.2 1.36 1.22–1.51 *** 45.1 49.9 1.41 1.31–1.53 ***
0 diagnosis 84.2 37.3 1.00 Ref. d 55.1 31.5 1.00 Ref. d
1 diagnosis 11.4 48.9 1.21 1.06–1.38 ** 24.4 44.5 1.26 1.13–1.39 ***
2 diagnoses 2.7 62.8 1.55 1.34–1.80 *** 10.6 54.3 1.56 1.40–1.75 ***
 3 diagnoses 1.7 67.4 1.76 1.50–2.06 *** 9.9 59.2 1.69 1.52–1.87 ***
*P < 0.05; **P < 0.01; ***P < 0.001. aGeneralized anxiety disorder; bwith or without agoraphobia; cobsessive-compulsive disorder; dP for linear trend
among number of diagnoses: < 0.001. NS: not significant.
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made a dummy variable indicating whether they had
started to smoke at t2 (yes/no). This variable was used as
the dependent variable, while each of the mental disor-
ders (separate analyses for 12-month prevalence and life-
time prevalence) at t1 were used as predictors, while
adjusting for demographic variables.
In order to report correct 95% confidence intervals of
the key statistics and P-values under weighting, so-called
‘robust’ variance-related estimates were obtained in all
analyses, using the first-order Taylor series linearization
method, as implemented in STATA. All analyses were
conductedwith STATA/SE forWindows, version 8.2 [33].
RESULTS
Cross-sectional association between prevalence of
smoking and mental disorder
In the past year, 39.8% of the population had smoked and
15.8% had had a mental disorder. The prevalence of
smoking was significantly higher among subjects with a
mental disorder (53.2%) than among subjects without a
mental disorder (37.3%; RR = 1.36; P < 0.001; Table 1).
The prevalence of smoking in the past year was increased
significantly in most mental disorders, except for general-
ized anxiety disorder (GAD), obsessive compulsive disor-
der (OCD) and alcohol abuse. The prevalence of smoking
increased with the number of comorbid mental disorders
(P for linear trend < 0.001). Smoking in the past year was
also related significantly to life-time mental disorders
except for OCD, and again, more diagnoses were
associated with higher rates of tobacco use (P for linear
trend < 0.001).
Do subjects who smoke have an increased risk of
developing a mental disorder for the first time in their
lives?
Among the subjects who had never had amental disorder
in their life at t1 (n = 2726), 6.8% had developed amental
disorder for the first time in their life at t2 (n = 167).
Among the subjects who had never had a mental disor-
der, 27.6% smoked (9.5% smoked one to nine cigarettes
per day, 10.5% 10–19 cigarettes and 7.5%more than 20
cigarettes; mean number of cigarettes smoked per day:
10.95; 95% CI: 11.63–1.24).
The risk of developing a mental disorder was signifi-
cantly higher in subjects who smoked at t1 than in sub-
jects who did not smoke at t1 (IRR = 1.62; P < 0.01;
Table 2), and this remained significant after controlling
for other risk indicators (IRR = 1.56; P < 0.05).
We also found that smoking was associated with
developing an anxiety disorder (IRR = 1.77) and a
substance-related disorder (IRR = 2.42), and both
remained significant after controlling for other risk indi-
cators. Specific disorders the incidence of which was
related to smoking were GAD (IRR = 3.80), dysthymia
(RR = 7.54) and alcohol abuse (RR = 2.32). Three sub-
jects were first-ever incident cases of a drug-related dis-
order (abuse or dependence); all three of them had
smoked at t1 and two subjects were first-ever incident
cases of obsessive-compulsive disorders; both had smoked
Table 2 Smoking as a risk indicator of first-ever incidence of mental disorders: incidence rate ratios (IRR).
%a
Adjusted for demographics
Adjusted for demographics
and other risk indicators
IRR 95% CI P IRR 95% CI P
Any anxiety disorder 2.67 1.88 1.15–3.06 * 1.77 1.10–2.86 *
GADb 0.64 4.57 1.53–13.67 ** 3.80 1.09–13.21 *
Panic disorderc 0.39 1.15 0.31–4.17 0.94 0.28–3.24
Agoraphobia 0.45 3.52 0.91–13.65 † 4.07 0.88–18.85 †
Social phobia 0.27 1.37 0.34–5.53 1.26 0.31–5.21
Simple phobia 1.51 1.59 0.84–3.02 1.50 0.82–2.73
Any mood disorder 2.76 1.53 0.93–2.51 † 1.41 0.84–2.39
Major depression 2.35 1.28 0.76–2.16 1.17 0.68–2.01
Dysthymia 0.53 6.61 1.77–24.62 ** 7.54 1.64–34.56 **
Bipolar disorder 0.32 6.45 0.55–75.65 8.97 0.47–171.79
Any substance use disorder 2.63 2.39 1.20–4.74 * 2.42 1.22–4.79 *
Alcohol abuse 2.29 2.32 1.09–4.98 * 2.32 1.09–4.96 *
Alcohol dependence 0.21 1.21 0.17–8.53 1.41 0.17–11.41
Any diagnosis 6.80 1.62 1.15–2.30 ** 1.56 1.10–2.22 *
†P < 0.1; *P < 0.05; **P < 0.01. aThis indicates the percentage of the population at risk (n = 2.726) who developed the mental disorder; bgeneralized
anxiety disorder; cwith or without agoraphobia.
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at t1. Because of the small number of subjects, we did not
conduct specific analyses for these disorders.
None of the analyses indicated any relationship
between the number of cigarettes smoked and the risk of
developing a mental disorder. This was true when the
number of cigarettes was used as a continuous variable,
andwhenwe used four categories of number of cigarettes
(zero; one to nine; 10–19;  20).
Do subjects with a mental disorder have an increased
risk of starting to smoke?
Among the subjects who did not smoke at t1, 4.9%
(n = 144) started smoking at t2. We examined whether
the subjects who did not smoke at t1 but did have amental
disorder had a higher probability of starting to smoke at
t2, compared with those who did not have that specific
mental disorder. We found that generalized anxiety disor-
der was associated with an increased risk of starting to
smoke, both 12-month (IRR = 4.46; P < 0.05) and life-
time (IRR = 4.46; P < 0.05). The same was true for drug
abuse (12-month: IRR = 5.88; P < 0.001; life-time:
IRR = 4.97; P < 0.01).
DISCUSSION
The most important finding of this study is that there is a
significant relationship between smoking and the devel-
opment of first-ever incident mental disorder at follow-
up. It has been well established in earlier studies that
smoking is elevated in subjects with mental disorders,
and some studies have found indications that smoking is
associated with an increased incidence of major depres-
sion [7,16]. We have now provided evidence that
smoking is associated with an increased risk of the first
incidence of several mental disorders.
We found that smoking is associated with an
increased risk for developing anxiety disorders and
substance-related disorders, and more specifically gener-
alized anxiety disorder, dysthymia and alcohol abuse.
Some recent studies have found that smoking at baseline
is associated with the onset of depression [7,16], while
other studies did not find such an association [17,18]. In
our study, we found no indication that smoking is associ-
ated with the incidence of major depression. Because all
studies in this area suffer from serious methodological
shortcomings, more research is needed to clarify this
issue.
Our finding that smoking is associated with the inci-
dence of alcohol abuse but not with the prevalence of
alcohol abuse, is remarkable and difficult to interpret. It
is, however, important to remember that these are two
different groups, and that those who develop alcohol
abuse during the follow-up period never met criteria for
alcohol abuse before in their lives.
Our results suggest that smoking may be a causal
factor in the aetiology of mental disorders. Such an aetio-
logical claim can be made—within reasonable bounds—
when the following criteria are met [19,34]: (1) there is a
probabilistic association between the assumed ‘cause’
(smoking) and the ‘effect’ (a mental disorder); (2) the
cause precedes the effect in time; and (3) the influence of
a confounder that causes both smoking and the mental
disorder can be ruled out. An aetiological claim can be
strengthened further when a dose–response relationship
can be found [19,34]. In our study, we found clear evi-
dence for the first two criteria, andwewere able to control
for a considerable number of possible confounders. It is,
however, never completely possible to rule out that a con-
founder which we did not examine has caused both the
smoking and the mental disorder. For example, it is well
established that physical activity levels are associated
with both smoking [35] and mental disorders [36,37],
and this could account for the associations observed in
this study. We have to conclude, therefore, that the third
criterion remains uncertain. Furthermore, we did not
find a dose–response relationship between smoking and
the risk for developing a mental disorder. We also found
evidence that subjects with a mental disorder have an
increased risk of starting to smoke, at least for generalized
anxiety disorder and drug abuse. This may also point
more towards a common cause for smoking and mental
disorders than to a causal relation between smoking and
the incidence of mental disorders.
Furthermore, it is remarkable that two of the mental
disorders we found to be associated with new mental dis-
orders are those that require the presence of symptoms
over a long period of time (generalized anxiety disorder
and dysthymia; 6 months in GAD and 2 years in dys-
thymia). Therefore, it is possible that symptoms of these
disorders may have been present at baseline, but that the
time criteria for the disorder were not yet present. In that
scenario, subjects would have been already in the prodro-
mal phase of the disorder during baseline, thus allowing
some room for the alternative hypothesis of reversed cau-
sality (i.e. first the disorder, then smoking).
The results of this study should be considered in the
light of its strengths and weaknesses. Its strengths
include the representativeness and the size of the sample,
the use of standardized diagnostic interviews in the full
sample and its prospective character. There are also limi-
tations, however. First, smoking was not assessed at the
first measurement, but only in the second and third mea-
surements. Because there was some dropout between the
first and the second measurements and between the
second and thirdmeasurements, and because there was a
small but significant association between dropout and
both mental disorders and smoking, the results may
have been somewhat distorted. Secondly, we measured
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smoking only in the past year, and not life-time. This
limited further analyses on the relationship between life-
time smoking andmental disorders, which is particularly
important because most people start smoking in adoles-
cence and our sample is older (18–65 years). Thirdly,
smoking status was not validated by biological measures
and so may be under-ascertained. Under-ascertainment
could reduce the strength of the association found.
Fourthly, the data are almost 10 years old and since then
the prevalence of smoking in the Netherlands has
decreased by about 6.3% (from 35.8% in 1997 to 29.5%
in 2005; Statistics Netherlands). Fifthly, because we
included only subjects who could speak Dutch, ethnic
minority groups were under-represented in our sample,
which may have influenced the results. Finally, although
the original sample was large, only a small number of
people developed a first-ever mental disorder during
follow-up.
Another limitation is the loss to follow-up. Possibly
this loss to follow-up is responsible for the association we
found between smoking and the development of mental
disorders. This seems unlikely, however. If there was truly
no association between smoking and mental disorders,
then among those lost to follow-up therewould have to be
a strong association in the opposite direction to that
observed in those followed. Given that most people were
followed (85.4%), the reverse association would have to
be stronger than the one observed.
Despite these limitations, this study is the first to
report evidence that smoking is associated with an
increased risk of developing amental disorder for the first
time. This is an important finding, once again suggestive
of the detrimental health effects of smoking.
References
1. Kalman D., Morissette S. B., George T. P. Co-morbidity of
smoking in patients with psychiatric and substance use dis-
orders. Am J Addict 2005; 14: 106–23.
2. De Leon J., Diaz F. J. A meta-analysis of worldwide studies
demonstrates an association between schizophrenia and
tobacco smoking behaviors. Schizophr Res 2005; 76: 135–
57.
3. Gonzalez-Pinto A., Gutierrez M., Ezcurra J., Aizpuru F.,
Mosquera F., Lopez P. et al. Tobacco smoking and bipolar
disorder. J Clin Psychiatry 1998; 59: 225–8.
4. Breslau N., Klein D. F. Smoking and panic attacks: an epi-
demiological investigation. Arch Gen Psychiatry 1999; 56:
1141–7.
5. Glassman A. H., Covey L. S., Stetner F., Rivelli S. Smoking
cessation and the course of major depression: a follow-up
study. Lancet 2001; 357: 1929–32.
6. Wu L. T., Anthony C. Tobacco smoking and depressedmood
in iate childhood and early adolescence. Am J Public Health
1999; 89: 1837–43.
7. Klungsøyr O., Nygard J. F., Sørensen T., Sandanger I. Ciga-
rette smoking and incidence of first depressive episode: an
11-year, population-based follow-up study. Am J Epidemiol
2006; 163: 421–32.
8. Miller N. S., Gold M. S. Comorbid cigarette and alcohol
addiction: epidemiology and treatment. J Addict Dis 1988;
17: 55–66.
9. Cuijpers P., Smit F. Nicotine dependence and regular nico-
tine use in adult children of alcoholics. Addict Res Theor
2002; 10: 69–81.
10. Sacco K. A., Bannon K. L., George T. P. Nicotinic receptor
mechanisms and cognition in normal states and neuropsy-
chiatric disorders. J Psychopharmacol 2004; 18: 457–74.
11. Lasser K., Boyd J. W., Woolhandler S., Himmelstein D. U.,
McCormick D., Bor D. H. Smoking and mental illness; a
population-based prevalence study. JAMA 2000; 284:
2606–10.
12. Addington J., el-Guebaly N., Campbell W., Hodgins D. C.,
Addington D. Smoking cessation treatment for patients
with schizophrenia. Am J Psychiatry 1998; 155: 974–6.
13. Kelly C., McCredie R. G. Smoking habits, current symptoms,
and premorbid characteristics of schizophrenic patients in
Nithsdale, Scotland. Am J Psychiatry 1999; 156: 1751–7.
14. Hall S. M., Munoz R. F., Reus V. I., Sees K. L. Nicotine,
negative affect and depression. J Consul Clin Psychol 1993;
61: 761–7.
15. Kendler K. S., Neale M. C., MacLean C. J., Heath A. C., Eaves
L. J., Kessler R. C. Smoking and major depression. A causal
analysis. Arch Gen Psychiatry 1993; 50: 36–43.
16. Lam T. H., Stewart S. M., Ho S. Y., Lai M. K., Mak K. H.,
Chau K. V. et al. Depressive symptoms and smoking among
Hong Kong Chinese adolescents. Addiction 2005; 100:
1003–11.
17. Fergusson D. M., Goodwin R. D., Horwood L. J. Major
depression and cigarette smoking: results of a 21-year lon-
gitudinal study. Psychol Med 2003; 33: 1357–67.
18. Murphy J. M., Horton N. J., Monson R. R., Laird N. M.,
Sobol A. M., Leighton A. H. Cigarette smoking in relation to
depression: historical trends from the Stirling County study.
Am J Psychiatry 2003; 160: 1663–9.
19. Rothman K. J., Greenland S.Modern Epidemiology, 2nd edn.
Philadelphia, PA: Lippincott-Raven; 1998.
20. Bijl R. V., Van Zessen G., Ravelli A. The Netherlands Mental
Health Survey and Incidence Study (NEMESIS): objectives
and design. Soc Psychiatry Psychiatr Epidemiol 1998; 33:
581–6.
21. Bijl R. V., Ravelli A., Van Zessen G. Prevalence of psychiatric
disorder in thegeneralpopulation: resultsof theNetherlands
Mental Health Survey and Incidence Study (NEMESIS). Soc
Psychiatry Psychiatr Epidemiol 1998; 33: 587–95.
22. De Graaf R., Bijl R. V., Smit F., Ravelli A., Vollebergh W. A.
Psychiatric and sociodemographic predictors of attrition in
a longitudinal study: the NetherlandsMental Health Survey
and Incidence Study (NEMESIS). Am J Epidemiol 2000; 152:
1039–47.
23. De Graaf R., Bijl R. V., Vollebergh W. A. M. Response and
Non-Response of the Third Wave of the Netherlands Mental
Health Survey and Incidence Study (NEMESIS). Technical
report. Utrecht: Netherlands Institute of Mental Health and
Addiction; 2000.
24. World Health Organization. Composite International Diagnos-
tic Interview (CIDI), version 1.0. Geneva: World Health
Organization; 1990.
25. Smeets R. M. W., Dingemans P. M. A. J. Composite Interna-
tional Diagnostic Interview (CIDI), version 1.1.Amsterdam:
World Health Organization; 1993.
1308 Pim Cuijpers et al.
© 2007 The Authors. Journal compilation © 2007 Society for the Study of Addiction Addiction, 102, 1303–1309
26. Wittchen H. U., Robins L. N., Cottler L. B., Sartorius N.,
Burke J. D., Regier D. Cross-cultural feasibility, reliability
and sources of variance in the Composite International
Diagnostic Interview (CIDI). Br J Psychiatry 1991; 159:
645–53.
27. Harris T., editor.Where Inner and OuterWorlds Meet: Psycho-
social Research in the Tradition of George W. Brown. London:
Routledge; 2000.
28. Smit F., Beekman A., Cuijpers P., de Graaf R., VolleberghW.
Selecting key-variables for depression prevention: results
from a population-based prospective epidemiological study.
J Affect Dis 2004; 81: 241–9.
29. Bijl R. V., de Graaf R., Ravelli A., Smit F., Vollebergh W. A.
et al. Gender and age-specific first incidence of DSM-III-R
psychiatric disorders in the general population. Results from
the Netherlands Mental Health Survey and Incidence Study
(NEMESIS). Soc Psychiatry Psychiatr Epidemiol 2002; 37:
372–9.
30. Cuijpers P., Smit F. Assessing parental alcoholism: a com-
parison of the family history research diagnostic criteria
versus a single question method. Addict Behav 2001; 26:
741–8.
31. Pearlin L. I., Schooler C. The structure of coping. J Health
Soc Behav 1978; 19: 2–21.
32. Ormel J. Moeite Met Leven of Moeilijk Leven [Difficulty with
Life, or a Difficult Life]. Groningen: Konstapel; 1980.
33. STATA Corporation. Stata/SE 8.2 for Windows. STATA sta-
tistical software. College Station, TX: Stata Corporation;
2004.
34. Smit F., Bolier L., Cuijpers P. Cannabis use and the risk
of later schizophrenia: a review. Addiction 2004; 99: 425–
30.
35. Brown D.W., Balluz L. S., Heath G.W., Moriarty D. G., Ford
E. S., Giles W. H., et al. Associations between recommended
levels of physical activity and health-related quality of life;
findings from the 2001 Behavioral Risk Factor Surveillance
System (BRFSS) survey. Prev Med 2003; 37: 520–8.
36. Dunn A. L., Trivedi M. H., O’Neal H. A. Physical activity
dose–response effects on outcomes of depression and
anxiety. Med Sci Sports Exerc 2001; 33: S587–97.
37. Sexton H., Sogaard A. J., Olstad R. How are mood and exer-
cise related? Results from the Finnmark Study. Soc Psychia-
try Psychiatr Epidemiol 2001; 36: 348–53.
Association of smoking with first mental disorder incidence 1309
© 2007 The Authors. Journal compilation © 2007 Society for the Study of Addiction Addiction, 102, 1303–1309
